Predictions
Teladoc Health Inc
Start price
Target price
Perf. (%)
€240.00
25.01.21
25.01.21
€350.00
25.01.22
25.01.22
-73.33%
26.01.22
26.01.22
Could be very worthwhile Investment >20% year
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€2.10
25.01.21
25.01.21
€3.00
25.01.22
25.01.22
63.56%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€36.75
25.01.21
25.01.21
€50.00
25.01.22
25.01.22
-12.24%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€7.55
25.01.21
25.01.21
€10.00
25.01.22
25.01.22
-2.65%
08.02.21
08.02.21
Could be very worthwhile Investment >20% year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€1.85
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-41.51%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.16
23.01.21
23.01.21
€30.00
23.01.22
23.01.22
-67.09%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€35.75
23.01.21
23.01.21
-
23.01.22
23.01.22
-73.67%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€67.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-26.99%
24.01.22
24.01.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€71.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-30.36%
24.01.22
24.01.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€219.23
21.01.21
21.01.21
€215.00
2.46%
15.02.21
15.02.21
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Crossject S.A.
Start price
Target price
Perf. (%)
€3.67
21.01.21
21.01.21
€10.00
21.01.22
21.01.22
-28.61%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Biocept Inc.
Start price
Target price
Perf. (%)
€147.00
21.01.21
21.01.21
€3,000.0
21.01.22
21.01.22
-48.16%
22.01.22
22.01.22
Could be very worthwhile Investment >20% year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€69.30
21.01.21
21.01.21
-
21.01.22
21.01.22
17.39%
29.06.21
29.06.21
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.13
11.01.21
11.01.21
€50.00
11.01.22
11.01.22
-5.37%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Asensus Surgical Inc.
Start price
Target price
Perf. (%)
€1.72
11.01.21
11.01.21
-
11.01.22
11.01.22
40.70%
19.01.21
19.01.21
Capable Management
Good culture
Dependend from some customers or products
Nuwellis Inc.
Start price
Target price
Perf. (%)
€6.40
11.01.21
11.01.21
€8.00
17.97%
25.01.21
25.01.21
Could be very worthwhile Investment >20% year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€0.79
11.01.21
11.01.21
€2.00
11.01.22
11.01.22
166.14%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€22.25
11.01.21
11.01.21
€75.00
11.01.22
11.01.22
65.17%
25.01.21
25.01.21
Could be worthwhile Investment >10% per year
Mediclin AG
Start price
Target price
Perf. (%)
€4.36
10.01.21
10.01.21
€6.00
10.01.22
10.01.22
-15.14%
11.01.22
11.01.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Medtronic plc
Start price
Target price
Perf. (%)
€97.71
10.01.21
10.01.21
-
10.01.22
10.01.22
-2.05%
11.01.22
11.01.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Known brand
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.22
04.01.21
04.01.21
€75.00
04.01.22
04.01.22
11.33%
05.09.21
05.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Sonic Healthcare
Start price
Target price
Perf. (%)
€20.80
31.12.20
31.12.20
€46.00
31.12.21
31.12.21
45.65%
01.01.22
01.01.22
Revenue growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High Investments for future growth
Hologic Inc.
Start price
Target price
Perf. (%)
€60.00
31.12.20
31.12.20
€78.00
31.12.21
31.12.21
10.17%
01.01.22
01.01.22
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected